Company Filing History:
1 out of 330 
1 out of 207 Years Active: 2005-2012
Title: Hartmut Rutten: Innovator in Pharmaceutical Chemistry
Introduction
Hartmut Rutten is a notable inventor based in Idstein, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target critical biological processes.
Latest Patents
Rutten holds a patent for "Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP)." This invention involves a series of 2,3,5-substituted pyridone derivatives, which are designed to inhibit the enzyme PARP. The compounds are particularly valuable as pharmaceutical agents, especially in treating and preventing diseases associated with the central nervous system and cardiovascular disorders.
Career Highlights
Hartmut Rutten has worked with Aventis Pharmaceuticals Inc., where he has been involved in innovative research and development. His work has contributed to advancements in therapeutic options for various medical conditions.
Collaborations
Rutten has collaborated with notable colleagues, including Philip M Weintraub and Paul Robert Eastwood. These collaborations have enhanced the scope and impact of his research.
Conclusion
Hartmut Rutten's contributions to pharmaceutical chemistry, particularly through his patent on pyridone derivatives, highlight his role as an innovator in the field. His work continues to influence the development of new therapeutic agents.